Trends and Finance

Roche launches COVID-19 PCR test to detect fast-spreading XBB.1.5 Omicron subvariant

XBB.1.5 is prevalent in the U.S. and is quickly spreading to other countries. It is a subvariant of a SARS-CoV-2 variant called XBB. That lineage is a recombinant of two descendants of the BA.2 lineage, which began spiking early in 2022.

January 26, 2023

Abbott CEO expects high single-digit sales growth excluding COVID-19 revenues in 2023

The firm booked diagnostics segment revenues of $3.31 billion in the fourth quarter, down 26.1% year over year. Nonetheless, its CEO sees some easing of macroenvironment challenges that impacted growth in 2022.

January 25, 2023

VieCure, Labcorp collaborate on clinical workflows, genomic testing

The firms are aiming to assist patient-specific treatment plans by integrating Labcorp’s precision medicine testing with VieCure’s clinical decision-support tool.

January 25, 2023

Quest survey: U.S. adults more comfortable with self-testing, but more familiar with horoscope sign than blood type

The prevalence of COVID-19 brought self-initiated testing to the forefront, Quest noted, with 4 in 5 surveyed claiming they're comfortable using at-home COVID tests.

January 23, 2023

With Bill & Melinda Gates Foundation grant, VisualDx to develop diagnostic, surveillance tools for underserved

The firm said it will use the funds to expand equitable access to its clinical decision support, artificial intelligence, and machine learning tools.

January 18, 2023

S2 Genomics, Bonsailab ink Spain, Portugal distribution agreement

S2 Genomics is partnering with Bonsailab to promote, sell, and support its Singulator 100 and 200 systems, which provide consistent isolation of single cells or nuclei from solid-tissue samples.

January 17, 2023

Most Popular

COVID-19 immune response strengthens over time: Study

Cardiovascular disease deaths undergo largest single-year increase since 2015

California sisters plead guilty in $7.5M Medicare fraud involving phlebotomy services

Study: One-third of ‘mostly young and healthy’ people develop long COVID symptoms

Roche launches COVID-19 PCR test to detect fast-spreading XBB.1.5 Omicron subvariant

AI tool makes speedy gene-editing possible, offers alternative to CRISPR

OpGen closes $7.5 million public offering

OpGen closed a public offering of an aggregate of 2.6 million shares of its common stock, Series A-1 warrants, to purchase the same amount of common stock and Series A-2 warrants at a combined public offering price of $2.90 per share.

January 17, 2023

Jumpcode Genomics enters PacBio’s Compatible Partner program

Jumpcode’s Single Cell RNA Boost Kit is compatible with PacBio’s Multiplexed Arrays Sequencing (MAS-Seq) for 10x Single Cell 3’ kit, which allows researchers to remove uninformative fragments from single-cell RNA sequencing libraries prior to sequencing.

January 12, 2023

After Illumina presentation highlighting Grail potential comes a possible EU fine

At the J.P. Morgan healthcare event this week, Illumina's CEO said Grail must be operated separately and independently pursuant to measures required by the EU.

January 12, 2023

Molecular diagnostic instrument vital in QuidelOrtho combination

At the 41st Annual J.P. Morgan Healthcare Conference on Monday, QuidelOrtho's CEO said the rollout of the Savannah molecular diagnostic platform was instrumental in the decision to combine the two firms.

January 10, 2023

Exact Sciences preliminary Q4 revenues rise 16% on strong screening sales

The firm expects screening revenue of $401.8 million to $402.8 million, an increase of 45% year-over-year. The screening business includes laboratory service revenue from Cologuard tests.

January 9, 2023

QuidelOrtho expects Q4 revenues between $853 million and $868 million

Its CEO said QuidelOrtho's strong positioning in the point-of-care market enabled it to serve patients in a strong respiratory season, which drove substantial revenue growth.

January 6, 2023

Page 1 of 109

Next Page